Fonar show increases in MRI scanner sales

Sales of its MRI units powered Fonar Corp. to greater revenues and a lower net loss in its third fiscal quarter, ending March 31.

Revenues advanced to $19.4 million, compared with $9.8 million in the third quarter of FY03. The company also posted a net loss of $1.5 million, compared with a net loss of $6.3 million in the year-ago quarter.

For the nine-month period, revenues reached $50.5 million, compared with $39 million in the same period of FY03. The net loss declined to $8 million, compared with a net loss of $12 million in the year-ago period.

In the third fiscal quarter, overall revenues from MRI product sales increased to $12.2 million, compared with $3.3 million in the year-ago quarter.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup